Design Therapeutics, Inc. - Common Stock (DSGN)

Historical Holders from Q1 2021 to Q3 2025

Symbol
DSGN on Nasdaq
CUSIP
25056L103
Type / Class
Equity / Common Stock
Shares outstanding
57.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
34.5M
Holdings value
$260M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
94
Number of buys
30
Number of sells
-49
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Design Therapeutics, Inc. - Common Stock (DSGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Light Irrevocable Trust #1 dated April 22, 2019 6.9% $14.8M 3.83M Light Irrevocable Trust #1 dated April 22, 2019 Dec 31, 2024
Star Irrevocable Trust #1 dated April 22, 2019 6.9% $14.8M 3.83M Star Irrevocable Trust #1 dated April 22, 2019 Dec 31, 2024
Point72 Asset Management, L.P. 5.2% $16.6M 2.94M Point72 Asset Management, L.P. Aug 27, 2025
Logos Global Management LP 4.4% -21.7% $16.3M -$4.8M 2.52M -22.7% Arsani William Nov 14, 2025

Institutional Holders of Design Therapeutics, Inc. - Common Stock (DSGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34.5M $260M +$644K $7.53 94
2025 Q2 34.5M $116M +$265K $3.37 91
2025 Q1 34.5M $133M +$2.13M $3.86 95
2024 Q4 33.5M $206M +$9.37M $6.17 94
2024 Q3 32M $172M +$1.33M $5.38 99
2024 Q2 32.1M $108M +$4.41M $3.35 92
2024 Q1 30.7M $124M -$2.84M $4.03 88
2023 Q4 14.1K $37.3K -$110K $2.65 1
2023 Q3 32.9M $77.6M -$68.5M $2.36 84
2023 Q2 38.8M $244M +$735K $6.30 96
2023 Q1 38.7M $223M -$16.1M $5.77 97
2022 Q4 40.4M $414M -$490K $10.26 80
2022 Q3 39.9M $667M +$24.3M $16.72 76
2022 Q2 38.5M $540M +$8.62M $14.00 67
2022 Q1 32.4M $523M +$27.8M $16.15 60
2021 Q4 30.5M $653M +$50.2M $21.41 56
2021 Q3 28.3M $415M +$5.45M $14.69 52
2021 Q2 27.8M $546M +$37.4M $19.89 48
2021 Q1 25.8M $755M +$755M $29.90 43